drugset / Trial / NCT00692016

Fast & Fed Pharmacokinetic (PK) Study

NCT00692016

Phase 1 Completed 32 enrolled Bayer
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to provide information on how well an extended release formulation (a medication that is released and absorbed over a longer period of time than a regular release formulation of the medication) of naproxen sodium is absorbed into the bloodstream after eating a high calorie breakfast and also after fasting (not eating for 14 hours).

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Naproxen Small molecule Oral

Indications

No indication recorded.